Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

MINT-ABACAVIR

MINT PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MINT-ABACAVIR in Canada?

A shortage of MINT-ABACAVIR 300MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated July 27, 2026), but it has not started yet.

Why is MINT-ABACAVIR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MINT-ABACAVIR be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file2 products
Expected resolution~4 months remaining (estimate)
Affected strength300MG
Last updated2026-07-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

APO-ABACAVIR

APOTEX INC

300MG · DIN 02396769

Same strengthSame dosage formSame routeNo current shortage

Other Products

ZIAGEN

VIIV HEALTHCARE ULC

20MG · DIN 02240358

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02480956

Strength

300MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ABACAVIR

See all ABACAVIR products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History